[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
AI::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 29, Issue 2 (Bimothly 2025) ::
Feyz Med Sci J 2025, 29(2): 183-188 Back to browse issues page
Epidemiology of perforated peptic ulcer: A report of 80 cases from Shahid Beheshti Hospital, Kashan, Iran
Nushin Moussavi-Biuki * , Ehsan Amiri , Hamidreza Gilasi , Mehdi Rajabi
Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran , n.moussavi@yahoo.com
Abstract:   (413 Views)
Background and Aim: Peptic ulcer disease is a common condition worldwide, affecting individuals across all age groups. Approximately 5% of patients with peptic ulcers develop perforation during their lifetime, which can lead to serious complications and even mortality. This study aimed to determine the demographic characteristics of patients diagnosed with perforated peptic ulcer at Shahid Beheshti Hospital in Kashan.
Methods: In this case series study, we examined all patients who underwent surgery for perforated peptic ulcer at Shahid Beheshti Hospital in Kashan between 2017 and 2022 (1396-1401 SH). Data including age, sex, perforation site (stomach or duodenum), and underlying factors were extracted from medical records through census method and analyzed using SPSS version 26.
Results: Among 80 patients with perforated peptic ulcer, 73.8% had duodenal perforation (mean age: 47.8 years) and 26.3% had gastric perforation (mean age: 49.4 years). In the duodenal group, smoking (66.1% vs 47.6%) and drug abuse (32.2% vs 19%) were more prevalent compared to the gastric group, while other factors such as NSAID use, steroid use, and cardiovascular disease were similar between the two groups. Female patients outnumbered males in both groups.
Conclusion: Contrary to similar studies, our findings showed a higher prevalence of perforated peptic ulcer among women compared to men in our population. This may be attributed to lower rates of smoking and alcohol consumption among men in our region compared to other countries, along with higher consumption of non-steroidal anti-inflammatory drugs or aspirin in the studied population.
Keywords: Peptic ulcer perforation, Duodenum, Non-steroidal anti-inflammatory drugs, Risk factors, Epidemiology
Full-Text [PDF 334 kb]   (67 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2024/10/21 | Revised: 2025/07/8 | Accepted: 2025/05/27 | Published: 2025/07/1
References
1. Xie X, Ren K, Zhou Z, Dang C, Zhang H. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol. 2022; 22(1): 58.doi:10.1186/s12876-022-02130-2 PMid:35144540 PMCid:PMC8832644
2. Ren J, Jin X, Li J, Li R, Gao Y, Zhang J, et al. The global burden of peptic ulcer disease in 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Int J Epidemiol. 2022; 51(5):1666-76. doi:10.1093/ije/dyac033 PMid:35234893
3. Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011; 84(2): 102-13. doi:10.1159/000323958 PMid:21494041
4. Mahlefahlo MT, Montwedi OD, Karusseit VOL. Perforated peptic ulcer - a case series and an African perspective. S Afr J Surg. 2024; 62(1): 66-71. doi:10.36303/SAJS.00161 PMid:38568129
5. Bupicha JA, Gebresellassie HW, Alemayehu A. Pattern and outcome of perforated peptic ulcer disease patient in four teaching hospitals in Addis Ababa, Ethiopia: a prospective cohort multicenter study. BMC Surg. 2020; 20(1):135. doi:10.1186/s12893-020-00796-7 PMCid:PMC7296920
6. Gbenga OJ, Ayokunle DS, Ganiyu A, Adekoya I. Pattern of Presentation, Management and Early Outcome in Patients with Perforated Peptic Ulcer Disease in a Semi-urban Tertiary Hospital. Ethiop J Health Sci. 2021;31(5):975-84. doi:10.4314/ejhs.v31i5.9 PMCid:PMC8843151
7. Seyoum N, Ethicha D, Assefa Z, Nega B. Risk Factors that Affect Morbidity and Mortality in Patients with Perforated Peptic Ulcer Diseases in a Teaching Hospital. Ethiop J Health Sci. 2020; 30(4): 549-58. doi:10.4314/ejhs.v30i4.10 PMid:33897215 PMCid:PMC8054450
8. Dakubo JC, Naaeder SB, Clegg-Lamptey JN. Gastro-duodenal peptic ulcer perforation. East Afr Med J. 2009;86(3):100-9. doi:10.4314/eamj.v86i3.54964 PMid:19702096
9. Choi YS, Heo YS, Yi JW. Clinical Characteristics of Primary Repair for Perforated Peptic Ulcer: 10-Year Experience in a Single Center. J Clin Med. 2021; 10(8). doi:10.3390/jcm10081790 PMid:33924059 PMCid:PMC8073572
10. Boyd-Carson H, Doleman B, Cromwell D, Lockwood S, Williams JP, Tierney GM, et al. Delay in Source Control in Perforated Peptic Ulcer Leads to 6% Increased Risk of Death Per Hour: A Nationwide Cohort Study. World J Surg. 2020; 44(3): 869-75. doi:10.1007/s00268-019-05254-x PMid:31664496
11. Yamamoto K, Takahashi O, Arioka H, Kobayashi D. Evaluation of risk factors for perforated peptic ulcer. BMC Gastroenterol. 2018; 18(1): 28. doi:10.1186/s12876-018-0756-4 PMid:29448921 PMCid:PMC5815199
12. Shreya A, Sahla S, Gurushankari B, Shivakumar M, Rifai, Kate V, et al. Spectrum of perforated peptic ulcer disease in a tertiary care hospital in South India: predictors of morbidity and mortality. ANZ J Surg. 2024; 94(3): 366-70. doi:10.1111/ans.18831 PMid:38115644
13. Ali AM, Mohamed AN, Mohamed YG, Kelesoglu SI. Clinical presentation and surgical management of perforated peptic ulcer in a tertiary hospital in Mogadishu, Somalia: a 5-year retrospective study. World J Emerg Surg. 2022; 17(1): 23. doi:10.1186/s13017-022-00428-w PMid:35578285 PMCid:PMC9112500
14. Hernandez MC, Thorn MJ, Kong VY, Aho JM, Jenkins DH, Bruce JL, et al. Validation of the AAST EGS grading system for perforated peptic ulcer disease. Surgery. 2018; 164(4): 738-45.doi:10.1016/j.surg.2018.05.061 PMid:30082138
15. Sayehmiri K, Abangah G, Kalvandi G, Tavan H, Aazami S. Prevalence of peptic ulcer in Iran: Systematic review and meta-analysis methods. J Res Med Sci. 2018; 23: 8. doi:10.4103/jrms.JRMS_1035_16 PMid:29456565 PMCid:PMC5813297
16. Li CH, Chang WH, Shih SC, Lin SC, Bair MJ. Perforated peptic ulcer in southeastern Taiwan. J Gastroenterol Hepatol. 2010; 25(9):1 530-6.doi:10.1111/j.1440-1746.2010.06348.x PMid:20796151
17. Turan B, Eroglu H, Sultanoglu B, Demirbakan K. Methamphetamine-related peptic ulcer perforation: a growing medical concern. Ulus Travma Acil Cerrahi Derg. 2023; 29(12): 1357-63. doi:10.14744/tjtes.2023.53146 PMid:38073456 PMCid:PMC10767286
18. Narayanan M, Steinheber FU. The changing face of peptic ulcer in the elderly. Med Clin North Am. 1976; 60(6): 1159-72. doi:10.1016/S0025-7125(16)31873-9 PMid:790045
19. Tadesse M, Musie E, Teklewold B, Hailu E. Prevalence of H. Pylori in Perforated Peptic Ulcer Disease at Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. Ethiop J Health Sci. 2021; 31(5):969-74. doi:10.4314/ejhs.v31i5.8 PMCid:PMC8843141
20. Choi YJ, Kim TJ, Bang CS, Lee YK, Lee MW, Nam SY, et al. Changing trends and characteristics of peptic ulcer disease: A multicenter study from 2010 to 2019 in Korea. World J Gastroenterol. 2023; 29(44): 5882-93. doi:10.3748/wjg.v29.i44.5882 PMCid:PMC10725564
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moussavi-Biuki N, Amiri E, Gilasi H, Rajabi M. Epidemiology of perforated peptic ulcer: A report of 80 cases from Shahid Beheshti Hospital, Kashan, Iran. Feyz Med Sci J 2025; 29 (2) :183-188
URL: http://feyz.kaums.ac.ir/article-1-5249-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 29, Issue 2 (Bimothly 2025) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.03 seconds with 44 queries by YEKTAWEB 4714